These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 81506)

  • 1. Antitumor antibiotic bioactivation, biotransformation and derivatization by microbial systems.
    Rosazza JP
    Recent Results Cancer Res; 1978; 63():58-68. PubMed ID: 81506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tallysomycin, a new antitumor antibiotic complex related to bleomycin. IV. New biosynthetic derivatives of tallysomycin.
    Miyaki T; Tenmyo O; Numata K; Matsumoto K; Yamamoto H; Nishiyama Y; Ohbayashi M; Imanishi H; Konishi M; Kawaguchi H
    J Antibiot (Tokyo); 1981 Jun; 34(6):658-64. PubMed ID: 6168630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tallysomycin, a new antitumor antibiotic complex related to bleomycin. V. Production, characterization and antitumor activity of tallysomycin S10b, a new biosynthetic tallysomycin derivative.
    Miyaki T; Numata K; Nishiyama Y; Tenmyo O; Hatori M; Imanishi H; Konishi M; Kawaguchi H
    J Antibiot (Tokyo); 1981 Jun; 34(6):665-74. PubMed ID: 6168631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial transformations of natural antitumor agents. 3. Conversion of thalicarpine to (+)-hernandalinol by Streptomyces punipalus.
    Nabih T; Davis PJ; Caputo JF; Rosazza JP
    J Med Chem; 1977 Jul; 20(7):914-7. PubMed ID: 141523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the mechanism of reductive activation in the mode of action of some anticancer drugs.
    Favaudon V
    Biochimie; 1982 Jul; 64(7):457-75. PubMed ID: 6181817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial models for drug metabolism.
    Rosazza JP; Smith RV
    Adv Appl Microbiol; 1979; 25():169-208. PubMed ID: 397736
    [No Abstract]   [Full Text] [Related]  

  • 7. Microbial transformations of natural antitumor agents, 25. Conversions of 3-ketoaphidicolin.
    Ipsen J; Rosazza JP
    J Nat Prod; 1984; 47(3):497-503. PubMed ID: 6434698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic and antitumor antibiotics produced by microorganisms.
    Oki T
    Biotechnol Bioeng; 1980; 22 Suppl 1():83-97. PubMed ID: 6159010
    [No Abstract]   [Full Text] [Related]  

  • 9. Microbial transformations of glaucine.
    Davis PJ; Wiese D; Rosazza JP
    J Chem Soc Perkin 1; 1977; 1():1-6. PubMed ID: 401819
    [No Abstract]   [Full Text] [Related]  

  • 10. Current developments in antitumor antibiotics, epipodophyllotoxins, and vinca alkaloids.
    Rowinsky EK
    Curr Opin Oncol; 1991 Dec; 3(6):1060-9. PubMed ID: 1843108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor antibiotics, epipodophyllotoxins, and vinca alkaloids.
    Hande KR
    Curr Opin Oncol; 1992 Dec; 4(6):1080-8. PubMed ID: 1457522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strain improvement by combined UV mutagenesis and ribosome engineering and subsequent fermentation optimization for enhanced 6'-deoxy-bleomycin Z production.
    Zhu X; Kong J; Yang H; Huang R; Huang Y; Yang D; Shen B; Duan Y
    Appl Microbiol Biotechnol; 2018 Feb; 102(4):1651-1661. PubMed ID: 29279956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of new anthracycline antibiotics by microbial 4-O-methylation using a specific daunorubicin-negative mutant.
    Johdo O; Tone H; Okamoto R; Yoshimoto A; Takeuchi T
    J Antibiot (Tokyo); 1992 Dec; 45(12):1837-47. PubMed ID: 1490874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial transformations of natural antitumor agents. 13. Conversions of 13-blocked anthracyclinones.
    Wu GS; Gard A; Rosazza JP
    J Antibiot (Tokyo); 1980 Jul; 33(7):705-10. PubMed ID: 7190964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic analysis in living cells of the inhibition of the P-glycoprotein-mediated efflux of anthracyclines by vinca alkaloids.
    Pereira E; Tarasiuk J; Garnier-Suillerot A
    Chem Biol Interact; 1998 Jul; 114(1-2):61-76. PubMed ID: 9744556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial conversion products of leptomycin B.
    Kuhnt M; Bitsch F; Ponelle M; Sanglier JJ; Wang Y; Wolff B
    Appl Environ Microbiol; 1998 Feb; 64(2):714-20. PubMed ID: 9464413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of resistance to anthracyclines and vinca alkaloids.
    Danø K; Skovsgaard T; Nissen NI; Friche E; Di Marco A
    Prog Clin Biol Res; 1983; 132C():231-46. PubMed ID: 6579564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of nocardicyclins by clinical isolates of Nocardia pseudobrasiliensis and in vivo antitumor activity of the antibiotic.
    Tanaka Y; Gräefe U; Yazawa K; Mikami Y
    J Antibiot (Tokyo); 1998 Jun; 51(6):589-91. PubMed ID: 9711224
    [No Abstract]   [Full Text] [Related]  

  • 19. Biotechnological applications of microbial bioconversions.
    Perkins C; Siddiqui S; Puri M; Demain AL
    Crit Rev Biotechnol; 2016 Dec; 36(6):1050-1065. PubMed ID: 26383603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor antibiotics: bleomycin, enediynes, and mitomycin.
    Galm U; Hager MH; Van Lanen SG; Ju J; Thorson JS; Shen B
    Chem Rev; 2005 Feb; 105(2):739-58. PubMed ID: 15700963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.